Skip to main content
T

Trilliome

Trilliome develops precision microbiome bioactives that target gut‑brain‑immune pathways to support healthy aging. Their flagship ingredient, TRI‑01, is a plant‑derived compound that selectively nourishes gut bacteria linked to anti‑inflammatory and neuroprotective metabolite production. The ingredient is formulated for inclusion in supplements and functional foods, backed by ex‑vivo data and advancing toward clinical validation.

Zürich, SwitzerlandFounded 20195500+ followers
Updated 4 months ago

Funding

$10K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Many commercially available supplements offer broad, non-targeted support for gut health, often failing to address the specific needs of an individual's microbiome. This can lead to inconsistent results and a lack of significant improvement in overall well-being. Furthermore, sourcing practices for plant extracts used in supplements are not always ethical or sustainable.

Solution

Trilliome develops precision nutraceuticals designed to target specific beneficial bacteria strains within the gut microbiome, promoting enhanced brain, mood, and metabolic well-being. Their approach utilizes a next-generation pre/probiotic fusion, combining prebiotics and probiotics for amplified efficacy. The company sources potent extracts from lesser-known plants with clinically validated benefits, ensuring both efficacy and sustainability. Trilliome's formulations are designed to stimulate the growth of beneficial bacteria strains that are often difficult to cultivate naturally, maximizing their impact on gut health and overall health outcomes.

Target Audience

Trilliome's primary customers are individuals seeking to improve their gut health, mood, cognitive function, and overall well-being through targeted, scientifically-backed nutraceuticals.

Features

  • Targeted microbiome modulation to feed specific beneficial bacteria strains linked to improved brain health, digestion, and immunity.
  • Next-gen pre/probiotic fusion for amplified efficacy.
  • Sourcing of potent extracts from lesser-known plants with clinically validated benefits.
  • Improvements in mood, cognitive function, and gut health markers.
  • Sustainable and ethical sourcing practices.
This profile is AI-generated and may contain inaccuracies.